417 related articles for article (PubMed ID: 26679962)
1. Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma.
Makhinova T; Barner JC; Richards KM; Rascati KL
J Manag Care Spec Pharm; 2015 Dec; 21(12):1124-32. PubMed ID: 26679962
[TBL] [Abstract][Full Text] [Related]
2. Adequate levels of adherence with controller medication is associated with increased use of rescue medication in asthmatic children.
Elkout H; Helms PJ; Simpson CR; McLay JS
PLoS One; 2012; 7(6):e39130. PubMed ID: 22761728
[TBL] [Abstract][Full Text] [Related]
3. Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting.
Chastek B; Korrer S; Nagar SP; Albers F; Yancey S; Ortega H; Forshag M; Dalal AA
J Manag Care Spec Pharm; 2016 Jul; 22(7):848-61. PubMed ID: 27348285
[TBL] [Abstract][Full Text] [Related]
4. Primary adherence to controller medications for asthma is poor.
Wu AC; Butler MG; Li L; Fung V; Kharbanda EO; Larkin EK; Vollmer WM; Miroshnik I; Davis RL; Lieu TA; Soumerai SB
Ann Am Thorac Soc; 2015 Feb; 12(2):161-6. PubMed ID: 25569765
[TBL] [Abstract][Full Text] [Related]
5. Seasonal patterns of controller and rescue medication dispensed in underserved children with asthma.
Butz AM; Thompson RE; Tsoukleris MG; Donithan M; Hsu VD; Mudd K; Zuckerman IH; Bollinger ME
J Asthma; 2008 Nov; 45(9):800-6. PubMed ID: 18972299
[TBL] [Abstract][Full Text] [Related]
6. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.
Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B
J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167
[TBL] [Abstract][Full Text] [Related]
7. Treatment with inhaled mometasone furoate reduces short-acting β(2) agonist claims and increases adherence compared to fluticasone propionate in asthma patients.
Navaratnam P; Friedman HS; Urdaneta E
Value Health; 2011; 14(2):339-46. PubMed ID: 21402302
[TBL] [Abstract][Full Text] [Related]
8. Impact of asthma controller medications on clinical, economic, and patient-reported outcomes.
Tan H; Sarawate C; Singer J; Elward K; Cohen RI; Smart BA; Busk MF; Lustig J; O'Brien JD; Schatz M
Mayo Clin Proc; 2009 Aug; 84(8):675-84. PubMed ID: 19648384
[TBL] [Abstract][Full Text] [Related]
9. Real-world patterns and implications of short-acting β
Lugogo N; Gilbert I; Tkacz J; Gandhi H; Goshi N; Lanz MJ
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):681-689.e1. PubMed ID: 33515710
[TBL] [Abstract][Full Text] [Related]
10. High oral corticosteroid exposure and overuse of short-acting beta-2-agonists were associated with insufficient prescribing of controller medication: a nationwide electronic prescribing and dispensing database analysis.
Sá-Sousa A; Almeida R; Vicente R; Nascimento N; Martins H; Freitas A; Fonseca JA
Clin Transl Allergy; 2019; 9():47. PubMed ID: 31559008
[TBL] [Abstract][Full Text] [Related]
11. Controller Medication Use and Exacerbations for Children and Adults With Asthma in High-Deductible Health Plans.
Galbraith AA; Ross-Degnan D; Zhang F; Wu AC; Sinaiko A; Peltz A; Xu X; Wallace J; Wharam JF
JAMA Pediatr; 2021 Aug; 175(8):807-816. PubMed ID: 33970186
[TBL] [Abstract][Full Text] [Related]
12. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
Barner JC; Khoza S; Oladapo A
Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
[TBL] [Abstract][Full Text] [Related]
13. Inhaled Corticosteroid-Containing Treatment Escalation and Outcomes for Patients with Asthma in a U.S. Health Care Organization.
Bengtson LGS; Yu Y; Wang W; Cao F; Hulbert EM; Wolbeck R; Elliott CA; Buikema AR
J Manag Care Spec Pharm; 2017 Nov; 23(11):1149-1159. PubMed ID: 29083972
[TBL] [Abstract][Full Text] [Related]
14. Underuse of controller medications among children with persistent asthma in the Ohio medicaid population: evolving differences with new medications.
Wilson SE; Leonard A; Moomaw C; Schneeweiss S; Eckman MH
Ambul Pediatr; 2005; 5(2):83-9. PubMed ID: 15780019
[TBL] [Abstract][Full Text] [Related]
15. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients.
Ismaila A; Corriveau D; Vaillancourt J; Parsons D; Stanford R; Su Z; Sampalis JS
Curr Med Res Opin; 2014 Jul; 30(7):1417-25. PubMed ID: 24666139
[TBL] [Abstract][Full Text] [Related]
16. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of risk factors and health outcomes among persons with asthma.
Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
[TBL] [Abstract][Full Text] [Related]
18. Overprescription of short-acting β
Al Zaabi A; Busaidi N; Al Mutairy S; Yorgancıoğlu A; Aksu K; Al-Jahdali H; Wali S; Elsayed M; Beekman MJ
Expert Rev Respir Med; 2022 Jul; 16(7):833-847. PubMed ID: 35848074
[TBL] [Abstract][Full Text] [Related]
19. Patient Outcomes, Health Care Resource Use, and Costs Associated with High Versus Low HEDIS Asthma Medication Ratio.
Luskin AT; Antonova EN; Broder MS; Chang E; Raimundo K; Solari PG
J Manag Care Spec Pharm; 2017 Nov; 23(11):1117-1124. PubMed ID: 29083971
[TBL] [Abstract][Full Text] [Related]
20. Assessment of basal insulin adherence using 2 methodologies among Texas Medicaid enrollees with type 2 diabetes.
Zhang H; Barner JC; Moczygemba LR; Rascati KL
J Manag Care Spec Pharm; 2020 Nov; 26(11):1434-1444. PubMed ID: 33119450
[No Abstract] [Full Text] [Related]
[Next] [New Search]
